JAMES WALDRON: Open Payments
NPI 1215054853 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 93 payments from 21 companies in 2025. Trend: 2023 $1,119 · 2024 $1,955 · 2025 $2,240
Food & beverage: $2,200Education: $40
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $266 |
| HARMONY BIOSCIENCES LLC | 6 | $245 |
| GlaxoSmithKline, LLC. | 15 | $226 |
| AstraZeneca Pharmaceuticals LP | 7 | $180 |
| Viatris Specialty LLC | 8 | $141 |
| Regeneron Healthcare Solutions, Inc. | 6 | $141 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $136 |
| Grifols USA, LLC | 6 | $134 |
| JAZZ PHARMACEUTICALS INC. | 4 | $131 |
| Axsome Therapeutics, Inc. | 6 | $126 |
Products named: DUPIXENT, WAKIX, NUCALA, YUPELRI, TEZSPIRE, LUMRYZ, XYWAV, Sunosi.
Industry payments across GA — which companies pay providers there.
